Kelman Lazarov Inc. increased its position in shares of GMO U.S. Quality ETF (NYSEARCA:QLTY – Free Report) by 4.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 380,573 shares of the company’s stock after purchasing an additional 14,716 shares during the quarter. GMO U.S. Quality ETF accounts for approximately 2.0% of Kelman Lazarov Inc.’s investment portfolio, making the stock its 18th largest holding. Kelman Lazarov Inc. owned 0.37% of GMO U.S. Quality ETF worth $13,769,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of QLTY. Vicus Capital increased its holdings in GMO U.S. Quality ETF by 436.9% in the 1st quarter. Vicus Capital now owns 139,323 shares of the company’s stock worth $5,041,000 after buying an additional 113,375 shares during the period. Colony Family Offices LLC lifted its stake in GMO U.S. Quality ETF by 7.9% during the 1st quarter. Colony Family Offices LLC now owns 487,099 shares of the company’s stock valued at $17,653,000 after acquiring an additional 35,746 shares during the period. Triangle Securities Wealth Management lifted its stake in GMO U.S. Quality ETF by 3.5% during the 1st quarter. Triangle Securities Wealth Management now owns 121,885 shares of the company’s stock valued at $4,410,000 after acquiring an additional 4,155 shares during the period. Breakwater Capital Group lifted its stake in GMO U.S. Quality ETF by 89.8% during the 1st quarter. Breakwater Capital Group now owns 24,449 shares of the company’s stock valued at $885,000 after acquiring an additional 11,568 shares during the period. Finally, Apella Capital LLC purchased a new stake in shares of GMO U.S. Quality ETF in the 1st quarter valued at $6,801,000. Hedge funds and other institutional investors own 85.37% of the company’s stock.
GMO U.S. Quality ETF Price Performance
NYSEARCA:QLTY opened at $41.70 on Friday. The firm has a market capitalization of $4.70 billion, a P/E ratio of 57.92 and a beta of 0.97. GMO U.S. Quality ETF has a 1-year low of $33.56 and a 1-year high of $41.95. The company’s fifty day moving average price is $40.78 and its 200-day moving average price is $39.22.
About GMO U.S. Quality ETF
The GMO U.S. Quality ETF (QLTY) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund that focuses on equities of high-quality US companies. The funds investments may include companies of any market capitalization. QLTY was launched on Nov 13, 2023 and is issued by GMO.
Featured Articles
- Five stocks we like better than GMO U.S. Quality ETF
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Want to see what other hedge funds are holding QLTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GMO U.S. Quality ETF (NYSEARCA:QLTY – Free Report).
Receive News & Ratings for GMO U.S. Quality ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Quality ETF and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg){kind=logo}